Results for 'biotechnology, convergence, CRISPR, gene therapy, mid-level principles, public engagement'

982 found
Order:
  1.  79
    CRISPR Gene-Therapy: A Critical Review of Ethical Concerns and a Proposal for Public Decision-Making.Victor Lange & Klemens Kappel - 2022 - Canadian Journal of Bioethics / Revue canadienne de bioéthique 5 (2):78.
    CRISPR is currently viewed as the central tool for future gene therapy. Yet, many prominent scientists and bioethicists have expressed ethical concerns around CRISPR gene therapy. This paper provides a critical review of concerns about CRISPR gene therapy as expressed in the mainstream academic literature, paired with replies also generally found in that literature. The expressed concerns can be categorised into three types depending on whether they stress risk/benefit ratio, autonomy and informed consent, or concerns related to (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  2.  74
    Gene Therapy Oversight: Lessons for Nanobiotechnology.Susan M. Wolf, Rishi Gupta & Peter Kohlhepp - 2009 - Journal of Law, Medicine and Ethics 37 (4):659-684.
    Oversight of human gene transfer research presents an important model with potential application to oversight of nanobiology research on human participants. Gene therapy oversight adds centralized federal review at the National Institutes of Health's Office of Biotechnology Activities and its Recombinant DNA Advisory Committee to standard oversight of human subjects research at the researcher's institution and at the federal level by the Office for Human Research Protections. The Food and Drug Administration's Center for Biologics Evaluation and Research (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   8 citations  
  3.  34
    In the Region of Middle Axioms: Judicial Dialogue as Wide Reflective Equilibrium and Mid-level Principles.José Juan Moreso & Chiara Valentini - 2021 - Law and Philosophy 40 (5):545-583.
    This article addresses the use of foreign law in constitutional adjudication. We draw on the ideas of wide reflective equilibrium and public reason in order to defend an engagement model of comparative adjudication. According to this model, the judicial use of foreign law is justified if it proceeds by testing and mutually adjusting the principles and rulings of our constitutional doctrines against reasonable alternatives, as represented by the principles and rulings of other reasonable doctrines. By this, a court (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  4.  96
    CRISPR: a new principle of genome engineering linked to conceptual shifts in evolutionary biology.Eugene V. Koonin - 2019 - Biology and Philosophy 34 (1):9.
    The CRISPR-Cas systems of bacterial and archaeal adaptive immunity have become a household name among biologists and even the general public thanks to the unprecedented success of the new generation of genome editing tools utilizing Cas proteins. However, the fundamental biological features of CRISPR-Cas are of no lesser interest and have major impacts on our understanding of the evolution of antivirus defense, host-parasite coevolution, self versus non-self discrimination and mechanisms of adaptation. CRISPR-Cas systems present the best known case in (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   13 citations  
  5.  41
    Wise therapy: philosophy for counsellors.Tim LeBon - 2001 - New York: Continuum.
    Independent on Sunday October 2nd One of the country's lead­ing philosophical counsellers, and chairman of the Society for Philosophy in Practice (SPP), Tim LeBon, said it typically took around six 50 ­minute sessions for a client to move from confusion to resolution. Mr LeBon, who has 'published a book on the subject, Wise Therapy, said philoso­phy was perfectly suited to this type of therapy, dealing as it does with timeless human issues such as love, purpose, happiness and emo­tional challenges. `Wise (...)
    Direct download  
     
    Export citation  
     
    Bookmark   8 citations  
  6.  89
    The Harm Principle as a Mid‐Level Principle? Three Problems From the Context of Infectious Disease Control.André Krom - 2011 - Bioethics 25 (8):437-444.
    Effective infectious disease control may require states to restrict the liberty of individuals. Since preventing harm to others is almost universally accepted as a legitimate (prima facie) reason for restricting the liberty of individuals, it seems plausible to employ a mid‐level harm principle in infectious disease control. Moral practices like infectious disease control support – or even require – a certain level of theory‐modesty. However, employing a mid‐level harm principle in infectious disease control faces at least three (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  7.  34
    Assessing public opinions on the likelihood and permissibility of gene editing through construal level theory.Derek So, Robert Sladek & Yann Joly - 2021 - New Genetics and Society 40 (4):473-497.
    Anticipatory policy for gene editing requires assessing public opinion about this new technology. Although previous surveys have examined respondents’ views on the moral acceptability of various hypothetical uses of CRISPR, they have not considered whether these scenarios are perceived as plausible. Research in construal level theory indicates that participants make different moral judgments about scenarios seen as likely or near and those seen as unlikely or distant. Therefore, we surveyed a representative sample of 400 Americans and Canadians (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  8.  40
    The genome editing revolution: A CRISPR‐Cas TALE off‐target story.Stefano Stella & Guillermo Montoya - 2016 - Bioessays 38 (S1):4-13.
    In the last 10 years, we have witnessed a blooming of targeted genome editing systems and applications. The area was revolutionized by the discovery and characterization of the transcription activator‐like effector proteins, which are easier to engineer to target new DNA sequences than the previously available DNA binding templates, zinc fingers and meganucleases. Recently, the area experimented a quantum leap because of the introduction of the clustered regularly interspaced short palindromic repeats (CRISPR)‐associated protein (Cas) system (clustered regularly interspaced short palindromic (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  9.  52
    Emerging sociotechnical imaginaries for gene edited crops for foods in the United States: implications for governance.Carmen Bain, Sonja Lindberg & Theresa Selfa - 2020 - Agriculture and Human Values 37 (2):265-279.
    Gene editing techniques, such as CRISPR, are being heralded as powerful new tools for delivering agricultural products and foods with a variety of beneficial traits quickly, easily, and cheaply. Proponents are concerned, however, about whether the public will accept the new technology and that excessive regulatory oversight could limit the technology’s potential. In this paper, we draw on the sociotechnical imaginaries literature to examine how proponents are imagining the potential benefits and risks of gene editing technologies within (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   10 citations  
  10.  92
    Breve storia dell'etica.Sergio Cremaschi - 2012 - Roma RM, Italia: Carocci.
    The book reconstructs the history of Western ethics. The approach chosen focuses the endless dialectic of moral codes, or different kinds of ethos, moral doctrines that are preached in order to bring about a reform of existing ethos, and ethical theories that have taken shape in the context of controversies about the ethos and moral doctrines as means of justifying or reforming moral doctrines. Such dialectic is what is meant here by the phrase ‘moral traditions’, taken as a name for (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   7 citations  
  11.  44
    De la bioéthique à l'action publique en matière de biotechnologies : la production des thérapies cellulaires.Virginie Tournay - 2006 - Cahiers Internationaux de Sociologie 121 (2):265-286.
    Cet article propose d’examiner la manière dont les pratiques médicales informelles utilisant les cellules humaines ont été réunies en une technologie intégrée sur deux décennies. Dans ce processus, les débats de la bioéthique constituent un dispositif d’épreuves permettant d’unifier ces pratiques disparates sous le label commun de « thérapie cellulaire ». En établissant des articulations possibles entre la production matérielle d’un savoir médical et ses inscriptions institutionnelles, le travail de requalification bioéthique s’effectue suivant trois registres. Tout d’abord, les controverses bioéthiques (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark  
  12. CRISPR as a Driving Force: The Model T of Biotechnology.Carlos Mariscal & Angel Petropanagos - 2016 - Monash Bioethics Review 34 (2):1-16.
    The CRISPR system for gene editing can break, repair, and replace targeted sections of DNA. Although CRISPR gene editing has important therapeutic potential, it raises several ethical concerns. Some bioethicists worry CRISPR is a prelude to a dystopian future, while others maintain it should not be feared because it is analogous to past biotechnologies. In the scientific literature, CRISPR is often discussed as a revolutionary technology. In this paper we unpack the framing of CRISPR as a revolutionary technology (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  13.  56
    Risk Communication for Nanobiotechnology: To Whom, about What, and Why?Susanna Hornig Priest - 2009 - Journal of Law, Medicine and Ethics 37 (4):759-769.
    Regulatory oversight and public communication are intimately intertwined. Oversight failures, both actual and perceived, quickly galvanize attention from both the media and the public, as has occasionally happened in all of the historical cases with which this symposium is concerned — gene therapy, workplace chemicals, drugs and devices, and genetically modified organisms, especially those used as foods. Some developments, such as GMOs, seem to have more cultural significance or “cultural resonance” than others and are especially likely to (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  14.  66
    Harm, ethics committees and the gene therapy death.Julian Savulescu - 2001 - Journal of Medical Ethics 27 (3):148-150.
    The recent tragic and widely publicised death of Jesse Gelsinger in a gene therapy trial has many important lessons for those engaged in the ethical review of research. One of the most important lessons is that ethics committees can give too much weight to ensuring informed consent and not enough attention to minimising the harm associated with participation in research. The first responsibility of ethics committees should be to ensure that the expected harm associated with participation is reasonable. Jesse (...)
    Direct download (5 more)  
     
    Export citation  
     
    Bookmark   21 citations  
  15.  17
    The Decision Phases Framework for Public Engagement: Engaging Stakeholders about Gene Editing in the Wild.S. Kathleen Barnhill-Dilling, Adam Kokotovich & Jason A. Delborne - 2021 - Hastings Center Report 51 (S2):48-61.
    Some experts and advocates propose environmental biotechnologies such as genetic engineering, gene drive systems, and synthetic biology as potential solutions to accelerating rates of species loss. While these tools may offer hope for a seemingly intractable problem, they also present potential governance challenges for which innovative decision‐making systems are required. Two of the perennial governance challenges include, when are broader stakeholder groups involved in these decisions and who exactly should be involved? We propose the decision phases framework—which includes research (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  16.  46
    Responsible data sharing in international health research: a systematic review of principles and norms.Shona Kalkman, Menno Mostert, Christoph Gerlinger, Johannes J. M. van Delden & Ghislaine J. M. W. van Thiel - 2019 - BMC Medical Ethics 20 (1):21.
    Large-scale linkage of international clinical datasets could lead to unique insights into disease aetiology and facilitate treatment evaluation and drug development. Hereto, multi-stakeholder consortia are currently designing several disease-specific translational research platforms to enable international health data sharing. Despite the recent adoption of the EU General Data Protection Regulation, the procedures for how to govern responsible data sharing in such projects are not at all spelled out yet. In search of a first, basic outline of an ethical governance framework, we (...)
    No categories
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   5 citations  
  17.  98
    The promise and peril of CRISPR gene drives.Gabriel E. Zentner & Michael J. Wade - 2017 - Bioessays 39 (10):1700109.
    Gene drives are selfish genetic elements that use a variety of mechanisms to ensure they are transmitted to subsequent generations at greater than expected frequencies. Synthetic gene drives based on the clustered regularly interspersed palindromic repeats genome editing system have been proposed as a way to alter the genetic characteristics of natural populations of organisms relevant to the goals of public health, conservation, and agriculture. Here, we review the principles and potential applications of CRISPR drives, as well (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  18.  11
    Biotechnology.Jennifer Kuzma - 2012 - In Jan Kyrre Berg Olsen Friis, Stig Andur Pedersen & Vincent F. Hendricks, A Companion to the Philosophy of Technology. Malden, MA: Wiley-Blackwell. pp. 523–531.
    This chapter contains sections titled: Decision‐making about New Technologies Case Studies for Biotechnology Guidance from the Public References and Further Reading.
    Direct download  
     
    Export citation  
     
    Bookmark  
  19.  18
    Medical Assistance in Dying for Persons Suffering Solely from Mental Illness in Canada.Chloe Eunice Panganiban & Srushhti Trivedi - 2025 - Voices in Bioethics 11.
    Photo ID 71252867© Stepan Popov| Dreamstime.com Abstract While Medical Assistance in Dying (MAiD) has been legalized in Canada since 2016, it still excludes eligibility for persons who have mental illness as a sole underlying medical condition. This temporary exclusion was set to expire on March 17th, 2024, but was set 3 years further back by the Government of Canada to March 17th, 2027. This paper presents a critical appraisal of the case of MAiD for individuals with mental illness as the (...)
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  20.  22
    Sequencing the salmon genome: A deliberative public engagement.David M. Secko, Michael Burgess & Kieran O'Doherty - 2010 - Genomics, Society and Policy 6 (1):1-18.
    Salmon genomics is an emerging field that represents a convergence between socially important scientific innovation and a politically volatile topic of significant interest to the public. These factors provide a strong rationale for public input. This report describes such input from a public engagement event based on the principles of deliberative democracy. The event involved a random, demographically stratified sample of 25 British Columbians (Canada). While some participants opposed sequencing the salmon genome on principle, on the (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  21.  6
    Biotechnology in Our Lives.Sheldon Krimsky & Jeremy Gruber (eds.) - 2013 - Skyhorse Publishing.
    For a quarter of a century, the Council for Responsible Genetics has provided a unique historical lens into the modern history, science, ethics, and politics of genetic technologies. Since 1983 the Council has had leading scientists, activists, science writers, and public health advocates researching and reporting on a broad spectrum of issues, including genetically engineered foods, biological weapons, genetic privacy and discrimination, reproductive technologies, and human cloning. Biotechnology in Our Lives examines how these issues affect us daily whether we (...)
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark  
  22. Attitudes Of The Public And Scientists To Biotechnology In Japan At The Start Of 2000.Mary Ann Ng, Chika Takeda, Tomoyuki Watanabe & Darryl Macer - 2000 - Eubios Journal of Asian and International Bioethics 10 (4):106-113.
    This survey on biotechnology and bioethics was carried out on national random samples of the public and scientists in November 2000-January 2000 throughout Japan, and attendees at the Novartis Life Science Forum held on 29 September, 1999 in Tokyo. The sample size was 297, 370, and 74 respectively. While there is better awareness of GMOs in 2000 compared to 1991; the trend shows an increase in the perceived risks of GMOs followed by growing resistance in Japan. While a majority (...)
     
    Export citation  
     
    Bookmark   1 citation  
  23.  72
    Defining the Scope of Public Engagement: Examining the “Right Not to Know” in Public Health Genomics.Clarissa Allen, Karine Sénécal & Denise Avard - 2014 - Journal of Law, Medicine and Ethics 42 (1):11-18.
    While the realm of bioethics has traditionally focused on the rights of the individual and held autonomy as a defining principle, public health ethics has at its core a commitment to the promotion of the common good. While these two domains may at times conflict, concepts arising in one may also be informative for concepts arising in the other. One example of this is the concept of a “right not to know.” Recent debate suggests that just as there is (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  24.  51
    The complexity of the gene and the precision of CRISPR : What is the gene that is being edited?Esha Shah, David Ludwig & Phil Macnaghten - 2021 - Elementa: Science of Anthropocene 9 (1):00072.
    The rapid development of CRISPR-based gene editing has been accompanied by a polarized governance debate about the status of CRISPR-edited crops as genetically modified organisms. This article argues that the polarization around the governance of gene editing partly reflects a failure of public engagement with the current state of research in genomics and postgenomics. CRISPR-based gene-editing technology has become embedded in a narrow narrative about the ease and precision of the technique that presents the (...) as a stable object under technological control. By tracing the considerably destabilized scientific understanding of the gene in genomics and postgenomics, this article highlights that this publicly mediated ontology strategically avoids positioning the “ease of CRISPR-based editing” in the wider context of the “complexity of the gene.” While this strategic narrowness of CRISPR narratives aims to create public support for gene-editing technologies, we argue that it stands in the way of socially desirable anticipatory governance and open public dialogue about societal promises and the unintended consequences of gene editing. In addressing the polarization surrounding CRISPR-based editing technology, the article emphasizes the need for engagement with the complex state of postgenomic science that avoids strategic simplifications of the scientific literature in promoting or opposing the commercial use of the gene-editing technology. (shrink)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  25. Improving the justice‐based argument for conducting human gene editing research to cure sickle cell disease.Berman Chan - 2019 - Bioethics 34 (2):200-202.
    In a recent article, Marilyn Baffoe-Bonnie offers three arguments for conducting CRISPR/Cas9 biotechnology research to cure sickle-cell disease (SCD) based on addressing historical and current injustices in SCD research and care. I show that her second and third arguments suffer from roughly the same defect, which is that they really argue for something else rather than for conducting CRISPR/Cas9 research in particular. For instance, the second argument argues that conducting this gene therapy research would improve the relationship between SCD (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  26. The ethics of human stem cell research.Gene H. Outka - 2002 - Kennedy Institute of Ethics Journal 12 (2):175-213.
    : The medical and clinical promise of stem cell research is widely heralded, but moral judgments about it collide. This article takes general stock of such judgments and offers one specific resolution. It canvasses a spectrum of value judgments on sources, complicity, adult stem cells, and public and private contexts. It then examines how debates about abortion and stem cell research converge and diverge. Finally, it proposes to extend the principle of "nothing is lost" to current debates. This extension (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   8 citations  
  27. Casuistry and principlism: The convergence of method in biomedical ethics. [REVIEW]Mark Kuczewski - 1998 - Theoretical Medicine and Bioethics 19 (6):509-524.
    Casuistry and principlism are two of the leading contenders to be considered the methodology of bioethics. These methods may be incommensurable since the former emphasizes the examination of cases while the latter focuses on moral principles. Conversely, since both analyze cases in terms of mid-level principles, there is hope that these methods may be reconcilable or complementary. I analyze the role of principles in each and thereby show that these theories are virtually identical when interpreted in a certain light. (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   18 citations  
  28. CRISPR and the Rebirth of Synthetic Biology.Raheleh Heidari, David Martin Shaw & Bernice Simone Elger - 2017 - Science and Engineering Ethics 23 (2):351-363.
    Emergence of novel genome engineering technologies such as clustered regularly interspaced short palindromic repeat has refocused attention on unresolved ethical complications of synthetic biology. Biosecurity concerns, deontological issues and human right aspects of genome editing have been the subject of in-depth debate; however, a lack of transparent regulatory guidelines, outdated governance codes, inefficient time-consuming clinical trial pathways and frequent misunderstanding of the scientific potential of cutting-edge technologies have created substantial obstacles to translational research in this area. While a precautionary principle (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  29.  53
    “CRISPR for Disabilities: How to Self-Regulate” or Something?Amanda Courtright-Lim - 2022 - Journal of Bioethical Inquiry 19 (1):151-161.
    The development of the CRISPR gene editing technique has been hyped as a technique that could fundamentally change scientific research and its clinical application. Unrecognized is the fact that it joins other technologies that have tried and failed under the same discourse of scientific hype. These technologies, like gene therapy and stem cell research, have moved quickly passed basic research into clinical application with dire consequences. Before hastily moving to clinical applications, it is necessary to consider basic research (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  30.  28
    Technoscience and Biodiversity Conservation.Christophe Boëte - 2018 - Asian Bioethics Review 10 (4):245-259.
    The discovery of CRISPR/cas9 has opened new avenues in gene editing. This system, usually considered as molecular scissors, permits the cutting of the DNA at a targeted site allowing the introduction of new genes or the removal or the modification of existing ones. The genome-editing, involving gene drive or not, is then considered with a strong interest in a variety of fields ranging from agriculture to public health and conservation biology. Given its controversial aspects, it is then (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  31.  43
    LeRoy Walters’s Legacy of Bioethics in Genetics and Biotechnology Policy.Robert Cook-Deegan & Stephen J. McCormack - 2019 - Kennedy Institute of Ethics Journal 29 (1):51-66.
    LeRoy Walters was a central figure in debates about federal policy regarding genetics and biotechnology—a neutral, publicly engaged philosopher and religious studies academic who put his skills to work in national service. His career spanned the emergence of biotechnology as a field in the 1970s until his retirement. His interests reached from moral philosophical theory to Holocaust studies to practical concerns about public policy in genetics. We focus here on the role of bioethics in policy related to the advent (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  32.  50
    CRISPR and the Ethics of Gene Drive in Mosquitoes.Tina Rulli - 2018 - In David Boonin, Palgrave Handbook of Philosophy and Public Policy. Cham: Palgrave Macmillan. pp. 509-521.
    CRISPR Cas9-powered gene drive allows for the rapid alteration of malaria-causing mosquitoes to spread an infertility gene or resistance to malaria among their species. Malaria eradication would be a great boon to human health. But many are concerned with driving genetic changes through a natural species. This chapter catalogs objections to the use of gene drive in mosquitoes for eradicating malaria. In-principle objections to gene drive use are not compelling. The most urgent concerns are related to (...)
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark  
  33.  23
    Public Health and Political Corporate Social Responsibility: Pharmaceutical Company Engagement in COVAX.Markus Scholz, N. Craig Smith, Maria Riegler & Anna Burton - 2024 - Business and Society 63 (4):813-850.
    Pharmaceutical companies developed Covid-19 vaccines in record time. However, it soon became apparent that global access to the vaccines was inequitable. Through a qualitative inquiry as the pandemic unfolded (to mid-2021), we provide an in-depth analysis of why companies engaged with the Covid-19 Vaccines Global Access Facility (COVAX), identifying the internal (to the company) and external factors that facilitated or impeded engagement. While all producers of the World Health Organization (WHO)-approved vaccines engaged with COVAX, our analysis highlights the differential (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  34.  22
    Improving the agri-food biotechnology conversation: bridging science communication with science and technology studies.Garrett M. Broad - 2023 - Agriculture and Human Values 40 (3):929-938.
    At a time when agri-food biotechnologies are receiving a surge of investment, innovation, and public interest in the United States, it is common to hear both supporters and critics call for open and inclusive dialogue on the topic. Social scientists have a potentially important role to play in these discursive engagements, but the legacy of the intractable genetically modified (GM) food debate calls for some reflection regarding the best ways to shape the norms of that conversation. This commentary argues (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  35.  69
    Informed consent and community engagement in open field research: lessons for gene drive science.Jerome Amir Singh - 2019 - BMC Medical Ethics 20 (1):54.
    The development of the CRISPR/Cas9 gene editing system has generated new possibilities for the use of gene drive constructs to reduce or suppress mosquito populations to levels that do not support disease transmission. Despite this prospect, social resistance to genetically modified organisms remains high. Gene drive open field research thus raises important questions regarding what is owed to those who may not consent to such research, or those could be affected by the proposed research, but whose consent (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  36.  58
    Why converging technologies need converging international regulation.Dirk Helbing & Marcello Ienca - 2024 - Ethics and Information Technology 26 (1):1-11.
    Emerging technologies such as artificial intelligence, gene editing, nanotechnology, neurotechnology and robotics, which were originally unrelated or separated, are becoming more closely integrated. Consequently, the boundaries between the physical-biological and the cyber-digital worlds are no longer well defined. We argue that this technological convergence has fundamental implications for individuals and societies. Conventional domain-specific governance mechanisms have become ineffective. In this paper we provide an overview of the ethical, societal and policy challenges of technological convergence. Particularly, we scrutinize the adequacy (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  37.  18
    Genopolitics: Biotechnology Norms and the Liberal International Order.Jonathan Moreno - 2022 - In Tomas Zima & David N. Weisstub, Medical Research Ethics: Challenges in the 21st Century. Springer Verlag. pp. 35-45.
    What happens in the world’s most advanced life sciences laboratories, why those activities are important, and whether and how they can be brought under a uniform governance framework might be considered exquisitely esoteric matters in the context of the great geopolitical questions of our time. Nonetheless, the emerging issues in biotechnology—the use of living organisms to create new products and especially in the control of the human genome—represent a useful stress test for the future of the norms inherent in the (...)
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark  
  38.  27
    A Crispr Revolution: The Brave New World of Cut-and-Paste Genetics.Sahotra Sarkar - 2021 - Rowman & Littlefield Publishers.
    The emergence of CRISPR/Cas9 technology has revolutionized gene editing and made both gene therapy and eugenic control of future human evolution plausible. This accessible book puts these developments in their historical and scientific contexts and analyzes the policy and ethical challenges they raise. It presents the case for altering the human germ-line to eliminate a large number of genetic diseases controlled by a single or few genes, while pointing out that gene therapy is likely to ineffective for (...)
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark  
  39.  25
    Ethical considerations of doll therapy for people with dementia.Gary Mitchell & Michelle Templeton - 2014 - Nursing Ethics 21 (6):720-730.
    The use of doll therapy for people with dementia has been emerging in recent years. Providing a doll to someone with dementia has been associated with a number of benefits which include a reduction in episodes of distress, an increase in general well-being, improved dietary intake and higher levels of engagement with others. It could be argued that doll therapy fulfils the concepts of beneficence (facilitates the promotion of well-being) and respect for autonomy (the person with dementia can exercise (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  40.  10
    Participatory Convergence: Integrating Convergence and Participatory Action Research.Laura Castro-Diaz, Anais Roque, Amber Wutich, Laura Landes, WenWen Li, Rhett Larson, Paul Westerhoff, Mariana Marcos-Hernandez, Mohammad Jobayer Hossain, Yushiou Tsai, Ramon Lucero, Griffin Todd, Dave White & Michael Hanemann - forthcoming - Minerva:1-21.
    This paper introduces the concept of “Participatory Convergence” as a framework to meet grand social-ecological challenges. Participatory Convergence combines the principles of Convergence Research with Participatory Action Research (PAR), offering a novel approach to tackling complex societal problems. Convergence Research seeks to foster high-level integration between diverse disciplines to address multifaceted issues, emphasizing systems thinking and solutions orientation; however, existing literature falls short in providing practical models for the deep integration of diverse disciplines, community partners, and community members. This (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  41.  86
    Biotechnology and the Fear of Frankenstein.Courtney S. Campbell - 2003 - Cambridge Quarterly of Healthcare Ethics 12 (4):342-352.
    It is a commonplace in the scientific and corporate discourse advocating biotechnology that the public is largely uneducated or scientifically illiterate when it comes to understanding the research methods and goals of biotechnology. Public dissent from biotechnology is, in this understanding, based exclusively in irrational fears. The way to dispel these public fears is for scientists in the research community and among corporate culture to engage in education of the public. At one level, it is (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  42.  24
    A Novel Eukaryote‐Like CRISPR Activation Tool in Bacteria: Features and Capabilities.Yang Liu & Baojun Wang - 2020 - Bioessays 42 (6):1900252.
    CRISPR (clustered regularly interspaced short palindromic repeats) activation (CRISPRa) in bacteria is an attractive method for programmable gene activation. Recently, a eukaryote‐like, σ54‐dependent CRISPRa system has been reported. It exhibits high dynamic ranges and permits flexible target site selection. Here, an overview of the existing strategies of CRISPRa in bacteria is presented, and the characteristics and design principles of the CRISPRa system are introduced. Possible scenarios for applying the eukaryote‐like CRISPRa system is discussed with corresponding suggestions for performance optimization (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  43.  9
    Making Moral Images of Biotechnology.Nicholas Agar - 2004 - In Liberal Eugenics: In Defence of Human Enhancement. Wiley-Blackwell. pp. 39–63.
    This chapter contains section titled: Utilitarian and Kantian Advice about Enhancement Moral Images and Moral Consistency Midgley's Scepticism about Consistency Harvesting Stem Cells: Research or Therapy? Are Enhancement Technologies wrong because they are ‘Yucky’? Why Food is Different Are Enhancement Technologies Wrong because they will Destroy Meaning?
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark  
  44.  15
    Methodist Morals: Social Principles in the Public Church’s Witness.Wonchul Shin - 2018 - Journal of the Society of Christian Ethics 38 (1):205-206.
    In lieu of an abstract, here is a brief excerpt of the content:Reviewed by:Methodist Morals: Social Principles in the Public Church's Witness by Darryl W. StephensWonchul ShinMethodist Morals: Social Principles in the Public Church's Witness Darryl W. Stephens knoxville: university of tennessee press, 2016. 320 pp. $48.00Darryl W. Stephens's Methodist Morals presents a historical, theological, and ethical analysis of a particular form of social witness in the United Methodist Church (UMC): the Social Principles. Stephens mainly argues that the (...)
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  45. Moral principles for allocating scarce medical resources in an influenza pandemic.Marcel Verweij - 2009 - Journal of Bioethical Inquiry 6 (2):159--169.
    One of the societal problems in a new influenza pandemic will be how to use the scarce medical resources that are available for prevention and treatment, and what medical, epidemiological and ethical justifications can be given for the choices that have to be made. Many things may become scarce: personal protective equipment, antiviral drugs, hospital beds, mechanical ventilation, vaccination, etc. In this paper I discuss two general ethical principles for priority setting (utility and equity) and explain how these principles will (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   9 citations  
  46.  27
    Genome-edited versus genetically-modified tomatoes: an experiment on people’s perceptions and acceptance of food biotechnology in the UK and Switzerland.Angela Bearth, Gulbanu Kaptan & Sabrina Heike Kessler - 2022 - Agriculture and Human Values 39 (3):1117-1131.
    Biotechnology might contribute to solving food safety and security challenges. However, gene technology has been under public scrutiny, linked to the framing of the media and public discourse. The study aims to investigate people’s perceptions and acceptance of food biotechnology with focus on transgenic genetic modification versus genome editing. An online experiment was conducted with participants from the United Kingdom and Switzerland. The participants were presented with the topic of food biotechnology and more specifically with experimentally varied (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  47. Mid-Level Principles and Justification.Michael Bayles - 1986 - In James Roland Pennock & John William Chapman, Justification. New York: New York University Press. pp. 49--67.
     
    Export citation  
     
    Bookmark   6 citations  
  48.  51
    Measuring biotechnology employees' ethical attitudes towards a controversial transgenic cattle project: The ethical Valence matrix. [REVIEW]Bruce H. Small & Mark W. Fisher - 2005 - Journal of Agricultural and Environmental Ethics 18 (5):495-508.
    What is the relationship between biotechnology employees’ beliefs about the moral outcomes of a controversial transgenic research project and their attitudes of acceptance towards the project? To answer this question, employees (n=466) of a New Zealand company, AgResearch Ltd., were surveyed regarding a project to create transgenic cattle containing a synthetic copy of the human myelin basic protein gene (hMBP). Although diversity existed amongst employees’ attitudes of acceptance, they were generally: in favor of the project, believed that it should (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  49.  32
    A Brave New Eugenics?: Crispr and the Human Future.Sahotra Sarkar - 2021 - Rowman & Littlefield Publishers.
    The emergence of CRISPR/Cas9 technology has revolutionized gene editing and made both gene therapy and eugenic control of future human evolution plausible. This accessible book puts these developments in their historical and scientific contexts and analyzes the policy and ethical challenges they raise. It presents the case for altering the human germ-line to eliminate a large number of genetic diseases controlled by a single or few genes, while pointing out that gene therapy is likely to ineffective for (...)
    No categories
    Direct download  
     
    Export citation  
     
    Bookmark  
  50.  33
    The creation of the Belmont Report and its effect on ethical principles: a historical study.Akira Akabayashi, Eisuke Nakazawa & Hiroyuki Nagai - 2022 - Monash Bioethics Review 40 (2):157-170.
    AbstractThe Belmont Report continues to be held in high regard, and most bioethical analyses conducted in recent years have presumed that it affects United States federal regulations. However, the assessments of the report’s creators are sharply divided. Understanding the historic reputation of this monumental report is thus crucial. We first recount the historical context surrounding the creation of this report. Subsequently, we review the process involved in developing ethical guidelines and describe the report’s features. Additionally, we analyze the effect of (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
1 — 50 / 982